Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Gutsmann

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
Experimental & Molecular Medicine|June 17, 2017
Coupling killing to neutralization: combined therapy with ceftriaxone/Pep19-2.5 counteracts sepsis in rabbitsSergio Bárcena-Varela, Guillermo Martínez-de-Tejada, Lukas Martin, et al.
Plos One|July 22, 2015
Therapeutical Administration of Peptide Pep19-2.5 and Ibuprofen Reduces Inflammation and Prevents Lethal SepsisLena Heinbockel, Sebastian Marwitz, Sergio Barcena Varela, et al.
Antimicrobial Agents and Chemotherapy|July 8, 2010
New antiseptic peptides to protect against endotoxin-mediated shockThomas Gutsmann, Iosu Razquin-Olazarán, Ina Kowalski, et al.
Current Drug Targets|June 6, 2012
Bacterial cell wall compounds as promising targets of antimicrobial agents II. Immunological and clinical aspectsTobias Schuerholz, Sabine Dömming, Mathias Hornef, et al.
Innate Immunity|February 28, 2016
Enhancing actions of peptides derived from the γ-chain of fetal human hemoglobin on the immunostimulant activities of monophosphoryl lipid AArtur J Ulmer, Yani Kaconis, Lena Heinbockel, et al.
Antimicrobial Agents and Chemotherapy|January 16, 2013
Preclinical investigations reveal the broad-spectrum neutralizing activity of peptide Pep19-2.5 on bacterial pathogenicity factorsLena Heinbockel, Susana Sánchez-Gómez, Guillermo Martinez de Tejada, et al.
Scientific Reports|June 24, 2017
Characterisation of Plasmodium falciparum populations selected on the human endothelial receptors P-selectin, E-selectin, CD9 and CD151Nahla Galal Metwally, Ann-Kathrin Tilly, Pedro Lubiana, et al.
Scientific Reports|March 13, 2020
Adhesion between P. falciparum infected erythrocytes and human endothelial receptors follows alternative binding dynamics under flow and febrile conditionsPedro Lubiana, Philip Bouws, Lisa Katharina Roth, et al.
Plos Pathogens|August 12, 2022
The ESX-4 substrates, EsxU and EsxT, modulate Mycobacterium abscessus fitnessMarion Lagune, Vincent Le Moigne, Matt D Johansen, et al.
Current Drug Targets|June 6, 2012
Bacterial cell wall compounds as promising targets of antimicrobial agents I. Antimicrobial peptides and lipopolyaminesGuillermo Martínez de Tejada, Susana Sánchez-Gómez, Iosu Rázquin-Olazaran, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Experimental & Molecular Medicine|June 17, 2017
Coupling killing to neutralization: combined therapy with ceftriaxone/Pep19-2.5 counteracts sepsis in rabbitsSergio Bárcena-Varela, Guillermo Martínez-de-Tejada, Lukas Martin, et al.
Plos One|July 22, 2015
Therapeutical Administration of Peptide Pep19-2.5 and Ibuprofen Reduces Inflammation and Prevents Lethal SepsisLena Heinbockel, Sebastian Marwitz, Sergio Barcena Varela, et al.
Antimicrobial Agents and Chemotherapy|July 8, 2010
New antiseptic peptides to protect against endotoxin-mediated shockThomas Gutsmann, Iosu Razquin-Olazarán, Ina Kowalski, et al.
Current Drug Targets|June 6, 2012
Bacterial cell wall compounds as promising targets of antimicrobial agents II. Immunological and clinical aspectsTobias Schuerholz, Sabine Dömming, Mathias Hornef, et al.
Innate Immunity|February 28, 2016
Enhancing actions of peptides derived from the γ-chain of fetal human hemoglobin on the immunostimulant activities of monophosphoryl lipid AArtur J Ulmer, Yani Kaconis, Lena Heinbockel, et al.
Antimicrobial Agents and Chemotherapy|January 16, 2013
Preclinical investigations reveal the broad-spectrum neutralizing activity of peptide Pep19-2.5 on bacterial pathogenicity factorsLena Heinbockel, Susana Sánchez-Gómez, Guillermo Martinez de Tejada, et al.
Scientific Reports|June 24, 2017
Characterisation of Plasmodium falciparum populations selected on the human endothelial receptors P-selectin, E-selectin, CD9 and CD151Nahla Galal Metwally, Ann-Kathrin Tilly, Pedro Lubiana, et al.
Scientific Reports|March 13, 2020
Adhesion between P. falciparum infected erythrocytes and human endothelial receptors follows alternative binding dynamics under flow and febrile conditionsPedro Lubiana, Philip Bouws, Lisa Katharina Roth, et al.
Plos Pathogens|August 12, 2022
The ESX-4 substrates, EsxU and EsxT, modulate Mycobacterium abscessus fitnessMarion Lagune, Vincent Le Moigne, Matt D Johansen, et al.
Current Drug Targets|June 6, 2012
Bacterial cell wall compounds as promising targets of antimicrobial agents I. Antimicrobial peptides and lipopolyaminesGuillermo Martínez de Tejada, Susana Sánchez-Gómez, Iosu Rázquin-Olazaran, et al.
Pageof 13